News and Comments

REGENERON: A GREAT LESSON TO LEARN

  Thursday, May 05, 2011

First, we congratulate our subscribers who did not follow the skeptics and believed in the rationality of science and kept their Vertex’ (VRTX) and Regeneron’s (REGN) shares despite years of negative campaigns against the two firms. Following the rally in VRTX, another rally started in REGN for rational reasons. Both firms are among our TOP TEN selection. More...


Recent Postings


Archive


Tags

Amgen (AMGN) Editas (EDIT) Abbott Laboratories (ABT) SUNESIS PHARMACEUTICALS (SNSS) Micromet (MITI) NEKTAR (NKTR)) Multiple Myeloma Onyx (ONXX) IDERA (IDRA) Incyte (INCY) Prolor Biotech (PBTH) Benlysta (belimumab) Human Longevity (HLI) Ridaforolimus Roche (ROCHE) Agenus (AGEN AGOS (ARGS) Telaprevir Sanofi (SNA) Auspex (ASPX) ImmunoGen (IMGN) AERIE PHARMACEUTICALS Sanofi (SNY) ABBVIE (ABBV) Sequenom (SQNM) Elan (ELN) Vertex (VRTX) VANDA (VNDA) GUARDIAN HEALTH Array Pharmaceuticals (ARRY) OSI (OSIP) Ariad (ARIA) Alder Biopharmaceuticals (ALDR) Trastuzumab-DM1 Inovio (INO) ADVENTRIX (ANX) Sarepta (SRPT) Xoma (XOMA) SERES THERAPEUTICS (MCRB) KITE (KITE) JUNO (JUNO) Regeneron (REGN) Seattle Genetics (SGEN) ZALTRAP™ Ionis (IONS) C4 Therapeutics Dynavax (DVAX) GlaxoSmithKline (GSK) Sangamo (SGMO) ARGOS (ARGS) Intercept (ICPT) Exelixis (EXEL) Human Genome Sciences (HGSI) Prosensa (RNA) Anacor (ANAC) Valeant Pharmaceuticals International (VRX) Jazz Pharmaceuticals (JAZZ) Biocryst (BCRX) Velcade (bortezomib) Zerenex KERYX (KERX) Anadys (ANDS) Merck (MRK) Idenix (IDIX) Agenus (AGEN) Revlimid (lenolidamide) galapagos (GLPG) Illumina (ILMN) Aimmune Therapeutics (AIMT) ACADIA (ACAD) Mirati Therapeutics (MRTX) Intrexon (XON) BIOMARIN (BMRN) Theravance Bio Pharma (TBPH) CompuGen (CGEN) ARCA (ABIO) HALOZYME (HALO) Vitae Pharmaceuticals (VTAE) Gilead (GILD) TOKAI (TKAOI) Cytokinetics (CYTK) INNOVIVA (INVA) RenenxBio (RGNX) Global Cell Therapeutics (GBT) NANTKWEST (NK) Intermune (ITMN) Endometrial Cancer Pluristem (PSTI) SYNTA (SNTA) ISIS (ISIS) Dendreon (DNDN) Rapamune Theravance (THRX) Roche (RHHBY) Sanofi-Aventis (SAN) Ziofpharm (ZIOP) Spike Therapeutics (ONCE) Bristol-Myers Squibb (BMY) Genentech Tysabri Alnylam (ALNY) Biogen Idec (BIIB) PTC Therapeutics (PTCT) Galena (GALE) REGULUS (RGLS) Herceptin